Table 1 Percentages of benign and malignant lesions in the study population according to histopathology
From: Added value of contrast-enhanced spectral mammography in symptomatic patients with dense breasts
No. = 25 | |
|---|---|
Benign or malignant | |
Benign | 11 (44.0%) |
Malignant | 14 (56.0%) |
Histopathology | |
No abnormality | 1 (4.0%) |
IDC | 13 (52.0%) |
Fibroadenoma | 5 (20.0%) |
Lobular mastitis | 2 (8.0%) |
Lobular carcinoma | 1 (4.0%) |
Fibroadenosis | 1 (4.0%) |
Fibrocystic disease | 1 (4.0%) |
Diabetic mastopathy | 1 (4.0%) |